Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2016-05-24 (9 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SOISSONS (02200), Aisne
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
PHARMACIE DE MAUPAS : revenue, balance sheet and financial ratios
PHARMACIE DE MAUPAS is a French company
founded 9 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SOISSONS (02200),
this company of category PME
shows in 2025 a net income positive of 159 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE DE MAUPAS (SIREN 820477826)
Indicator
2025
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
159 036 €
100 034 €
141 102 €
143 357 €
161 997 €
122 941 €
126 174 €
105 635 €
87 864 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2025, PHARMACIE DE MAUPAS generates positive net income of 159 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2017-2025: 88 k€ -> 159 k€.
Net income (2025)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
159 036 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 30%. Debt remains under control: the company retains capacity to raise new debt if needed. Financial autonomy (= Equity / Total assets x 100) reaches 65%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2025)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
30.088%
Financial autonomy (2025)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
65.309%
Asset age ratio (2025)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Debt ratio
672.735
396.409
245.916
169.063
107.405
80.861
60.856
42.942
30.088
Financial autonomy
10.767
17.3
24.408
31.748
40.296
47.61
53.226
59.297
65.309
Repayment capacity
None
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
30.092025
2023
2024
2025
Q1: 13.57
Med: 49.47
Q3: 128.28
Good-10 pts over 3 years
In 2025, the debt ratio of PHARMACIE DE MAUPAS (30.09) ranks below the median of the sector. This ratio measures the weight of debt relative to equity. This controlled position reflects prudent management.
Financial autonomy
65.31%2025
2023
2024
2025
Q1: 33.69%
Med: 53.88%
Q3: 72.26%
Good+10 pts over 3 years
In 2025, the financial autonomy of PHARMACIE DE MAUPAS (65.3%) ranks above the median of the sector. This ratio represents the share of equity in total financing. This comfortable position offers an appreciable safety margin.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 215.88. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2025)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
215.879
Liquidity indicators evolution PHARMACIE DE MAUPAS
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
2025
Liquidity ratio
135.845
103.721
111.727
119.942
130.361
170.769
198.517
190.893
215.879
Interest coverage
None
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
215.882025
2023
2024
2025
Q1: 131.48
Med: 182.6
Q3: 258.72
Good+8 pts over 3 years
In 2025, the liquidity ratio of PHARMACIE DE MAUPAS (215.88) ranks above the median of the sector. This ratio measures the ability to cover short-term debt with current assets. This comfortable position offers an appreciable safety margin.
Positioning of PHARMACIE DE MAUPAS in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 277 transactions of similar company sales
in 2025,
the value of PHARMACIE DE MAUPAS is estimated at
2 526 305 €
(range 1 714 363€ - 3 964 121€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2025
277 transactions
1714k€2526k€3964k€
2 526 305 €Range: 1 714 363€ - 3 964 121€
NAF 5 année 2025
Valuation method used
Net Income Multiple
159 036 €
×
15.9x
=2 526 306 €
Range: 1 714 363€ - 3 964 122€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE DE MAUPAS with other companies in the same sector:
Frequently asked questions about PHARMACIE DE MAUPAS
What is the revenue of PHARMACIE DE MAUPAS ?
The revenue of PHARMACIE DE MAUPAS is not publicly disclosed (confidential accounts filed with INPI).
Is PHARMACIE DE MAUPAS profitable?
Yes, PHARMACIE DE MAUPAS generated a net profit of 159 k€ in 2025.
Where is the headquarters of PHARMACIE DE MAUPAS ?
The headquarters of PHARMACIE DE MAUPAS is located in SOISSONS (02200), in the department Aisne.
Where to find the tax return of PHARMACIE DE MAUPAS ?
The tax return of PHARMACIE DE MAUPAS is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE DE MAUPAS operate?
PHARMACIE DE MAUPAS operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart